Retatrutide (also referred to as LY3437943) is an investigational triple receptor agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Pharmacy2U Partners With Reset Health to Expand Digital Support for GLP-1 Weight Management Nicholas Saraceno, Senior Editor Key Takeaways Pharmacy2U will dispense GLP-1 obesity medicines nationwide while Reset Health delivers monthly teleconsults, nutrition, behavioral coaching, and psychological support via a remote platform starting Q1 2026
Seek immediate medical help if you develop symptoms of a severe allergic reaction, such as breathing difficulties, confusion, anxiety, clammy skin, and fainting.
While you wont be disappointed with semaglutide, tirzepatide may provide slightly superior results with a more favorable side effect profile
Azzini E, Raguzzini A, Polito A